Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/2857
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDilafruz Akhmedova, Mirkomil Tojiboyev, Munira Mahmudova-
dc.date.accessioned2022-10-10T17:08:30Z-
dc.date.available2022-10-10T17:08:30Z-
dc.date.issued2022-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/2857-
dc.description.abstractTo date, the treatment of OA is aimed primarily at the symptoms of the disease, i.e., to reduce pain and improve the functional state of the joints. The use of NSAIDs allows you to quickly reduce the intensity of pain and accelerate the recovery of motor activity in OA. However, the use of this group of drugs is associated with the development of adverse events in the gastrointestinal tract, cardiovascular system, kidneys and other organs, which is especially important in comorbid conditions in elderly patients. In this regard, it becomes clear that there is a high interest in the group of drugs with a delayed symptomatic effect, which have proven themselves excellently in arthrological practiceen_US
dc.language.isootheren_US
dc.publisherУкраинаen_US
dc.subjectosteoarthrosis, chondroitin sulfate, glucosamine, methylsulfonylmethaneen_US
dc.titleModern approaches to the treatment of osteoarthrosisen_US
dc.typeThesisen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
15.pdfModern approaches to the treatment of osteoarthrosis729.43 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.